BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 35406421)

  • 1. Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment.
    Zhang XR; Chien PN; Nam SY; Heo CY
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology and genetics of anaplastic large cell lymphoma.
    Leventaki V; Bhattacharyya S; Lim MS
    Semin Diagn Pathol; 2020 Jan; 37(1):57-71. PubMed ID: 31882178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
    Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A; Otsuki T; Vogelbruch M; Clark HM; Jaffe ES; Raffeld M
    Blood; 1995 Sep; 86(6):2321-8. PubMed ID: 7662979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
    Shustov A; Soma L
    Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
    Sarris AH; Luthra R; Papadimitracopoulou V; Waasdorp M; Dimopoulos MA; McBride JA; Cabanillas F; Duvic M; Deisseroth A; Morris SW; Pugh WC
    Blood; 1996 Sep; 88(5):1771-9. PubMed ID: 8781434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL).
    Montes-Mojarro IA; Steinhilber J; Bonzheim I; Quintanilla-Martinez L; Fend F
    Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29617304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALK-Negative Anaplastic Large Cell Lymphoma: Current Concepts and Molecular Pathogenesis of a Heterogeneous Group of Large T-Cell Lymphomas.
    Pina-Oviedo S; Ortiz-Hidalgo C; Carballo-Zarate AA; Zarate-Osorno A
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls.
    Montella M; LucĂ  S; Ronchi A; Marino FZ; Caputo A; Sica A; Zeppa P; Franco R; Cozzolino I
    Acta Cytol; 2023; 67(3):230-239. PubMed ID: 36634640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma.
    Gleason L; Afifi L; Banner L; Talasila S; Joffe D; Bhatti S; Alpdogan O; Porcu P; Nikbakht N
    Mol Clin Oncol; 2024 May; 20(5):35. PubMed ID: 38596625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in pathobiological aspects of anaplastic large cell lymphoma.
    Wu R; Lim MS
    Front Oncol; 2023; 13():1241532. PubMed ID: 37810974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic Large Cell Lymphoma Manifesting as Pleural Effusion in a Patient with Long-Standing Eosinophilia.
    Belludi CK; Qian ET; Tolle JJ; Brown RM; Thompson MA; Juskevicius R
    Lab Med; 2019 Jan; 50(1):87-92. PubMed ID: 30016448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
    George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
    Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
    Irshaid L; Xu ML
    Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast Implant-associated Anaplastic Large Cell Lymphoma.
    Alotaibi S; Hamadani M; Al-Mansour M; Aljurf M
    Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e272-e276. PubMed ID: 33384263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Implant-associated Anaplastic Large Cell Lymphoma: Review and Multiparametric Imaging Paradigms.
    Sharma B; Jurgensen-Rauch A; Pace E; Attygalle AD; Sharma R; Bommier C; Wotherspoon AC; Sharma S; Iyengar S; El-Sharkawi D
    Radiographics; 2020; 40(3):609-628. PubMed ID: 32302264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
    Xing X; Feldman AL
    Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 15-Year-Old Boy with Primary Maxillary Bone Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma Relapsed with Rib Metastasis after Spontaneous Remission of a Maxillary Bone Lesion: A Case Report and Literature Review.
    Aizawa K; Yamazaki F; Shima H; Kurosawa T; Ishikawa T; Nakazawa A; Shimada H
    Case Rep Oncol; 2023; 16(1):308-314. PubMed ID: 37187683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
    Oregel KZ; Everett E; Zhang X; Nagaraj G
    Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.